Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI (vol 52, pg 304, 2022)

Abstract

In the article, some unfortunate errors occurred and we would like to correct the errors as written below. The changes are underlined. Before Correction Funding This study was funded by Daiichi Sankyo, Boston Scientific, Terumo, Biotronik, Qualitech Korea, and Dio. This research was partially supported by a grant from Seoul National University Hospital (Research ID: 03-2021-0030). The funders of this study had no role in study design, collection of data and data analysis, or writing of the manuscript. After Correction Funding This study was funded by Daiichi Sankyo, Boston Scientific, Terumo, Biotronik, Qualitech Korea, and Dio. This research was partially supported by a grant from Seoul National University Hospital (Research ID: 30-2021-0030). The funders of this study had no role in study design, collection of data and data analysis, or writing of the manuscript. Copyright © 2022. The Korean Society of Cardiology